Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...
Zacks Investment Research on MSN
Stereotaxis stock up on first US MAGIC procedures post approval
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, ...
Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.
First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...
A catheter treatment is more effective than drug therapy in treating some patients with atrial fibrillation, according to new research. Atrial fibrillation is a common heart rhythm problem that ...
Forty-three cardiology and electrophysiology codes — spanning catheter ablations, coronary revascularization procedures, electrophysiologic evaluations, heart failure management techniques and ...
Stereotaxis has completed the first U.S. procedures using its FDA‑approved MAGiC robotic magnetic ablation catheter, designed for complex congenital heart disease cases where traditional approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results